GF and Hapa are offering pharmaceutical packaging technologies, including the H871 bfsjet for direct digital printing on Blow ...

Following recent approvals in the EU, China and the U.S., this approval was based on pivotal Phase 3 results in adults with elevated eosinophils ...

Dupixent approved as the first-ever biologic medicine in Japan for patients with COPDFollowing recent approvals in the EU, China, and the US, ...

Positive results from the ADEPT Phase II/III study indicate that Dupixent (dupilumab) may be effective in treating moderate-to-severe bullous pemphigoid (BP). The findings were presented at the 2025 ...

In April 2020, Dupixent, a novel prefilled pen from Sanofi that treats patients with atopic dermatitis, chronic rhinosinusitis, and asthma at home, received FDA approval in the U.S. Future Market ...